Skip to main content
. 2016 Mar-Apr;48(2):134–140. doi: 10.4103/0253-7613.178825

Figure 1.

Figure 1

Comparison of alfuzosin, tamsulosin and silodosin in benign prostatic hyperplasia: Flow of study participants